Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT07262034
Eligibility Criteria:
Inclusion Criteria:
1. Patients aged 60 years to 90 years
2. Schedules for elective major surgery and formally enrollment in the Enhanced Recovery After Surgery (ERAS) program at Siriraj Hospital. (At Siriraj Hospital, patients scheduled for pre-specific elective major surgeries are enrolled into the ERAS program as individual hospital protocols for each ERAS module. All patients are informed about the ERAS program by their surgical team.)
3. Referred to the SiPAP center for prehabilitation based on established ERAS hospital preoperative protocol.
4. Able to provide written informed consent and willing to undergo all research assessments at both time points.
Exclusion Criteria:
1. Presence of conditions that interfere with bioelectrical impedance analysis (BIA), including an implanted pacemaker or other non-removable electronic medical devices.
2. Use of medications or supplements known to acutely or chronically affect muscle mass (e.g. corticosteroids, hormonal therapies) during the study period.
3. Diagnosed neuromuscular disorders that affect baseline muscle mass and strength
4. Undergo emergency surgery
5. A planned interval of less than 14 days between the initial SiPAP visit and hospital admission for surgery.
6. Alcohol consumption or strenuous exercise within the 12 hours preceding the scheduled BIA measurement.
7. Incomplete data on muscle mass or nutritional assessment at either time point.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
90 Years
Study:
NCT07262034
Study Brief:
Protocol Section:
NCT07262034